#1Biome Australia Limited | August 2023 A Company ACTIVATED PROBIOTICS® Presentation Blair Norfolk, CEO & Managing Director Douglas Loh, CFO 200#2Biome Australia Commercial in confidence Disclaimer This presentation and the information contained within it (the "information") has been prepared solely for the use and benefit of the person to whom it is provided (the "recipient"). It has been provided to the recipient on a strictly confidential basis solely for the purpose of assisting the recipient to determine whether it may be interested in participating in the investment opportunity described in this presentation ("Opportunity") and if so, to participate in that process, and may only be used for that purpose. This presentation contains selected information only and does not purport to contain all of the information that may be relevant to the Opportunity. The information is not a prospectus, disclosure document, product disclosure statement or other offering document under Australian law or under any other law. This presentation has not been filed, registered or approved in any jurisdiction. The information is provided for general information purposes only, without taking into account any person's objectives, financial situation or needs. It should not be relied on by the recipient in considering the merits of any particular transaction, including the Opportunity. The recipient should consider its own financial situation, objectives and needs and conduct its own independent investigation and assessment of the contents of the Information. Past performance information included in this presentation is provided for illustrative purposes only, should not be relied upon and is not an indication of future performance. Biome Australia Limited ("Company") and its related bodies corporate, directors, officers, partners, employees, advisers, consultants and agents make no representation nor give any warranty, express or implied, as to the accuracy, completeness, reliability, timeliness or suitability of the information or that the information may be used in any given way or to achieve any given result. Any forward-looking statements or projections included within the information have been prepared by the Company and its representatives and represent the subjective views of the Company's management and representatives and their current estimates of future performance. These forward looking statements and projections are not guarantees or predictions of future performance and involve known and unknown risks and uncertainties and other factors, many of which are beyond the control of the Company, which may or may not prove to be correct and the recipient must form its own view on their subject matter. The Company is under no obligation to notify the recipient or provide further information to the recipient should the Company or its representatives become aware that any information is inaccurate or out of date, has changed or is incomplete. The recipient must, and agrees with the Company that it will, make its own independent assessment of the accuracy, completeness, reliability, timeliness and suitability of the information and its own determination of whether the information is appropriate to be used for any given purpose. The recipient will rely upon the information at its own risk. To the maximum extent permitted by law, the Company and its related bodies corporate, directors, officers, partners, employees, advisers, consultants and agents exclude and disclaim all liability for any expenses, losses, damages or costs incurred or suffered by the recipient or any other person arising from or in connection with use or reliance on (in any manner) the information or the recipient's participation in the Opportunity, whether the expenses, losses, damages or costs arise because of negligence, default, misrepresentation or some other cause, and whether or not foreseeable. To the maximum extent permitted by law, the recipient (on its own behalf and on behalf of each of its representatives) unconditionally and irrevocably releases the Company and its related bodies corporate, directors, officers, partners, employees, advisers, consultants and agents from all claims and liability. The Company holds this release for itself and on trust for its related bodies corporate, directors, officers, partners, employees, advisers, consultants and agents. Company Presentation | August 2023 2#3Biome Australia About Biome Australia Commercial in confidence A ACTIVATED PROBIOTICS To support healthy mood balance and enhance sleep quality Biome Lift™ Probiotic CTATED FOBOREY TED CS A ACTIVATED PROBIOTICS To help maintain a healthy vaginal microbiome Biome Her Probiotic Guaranteed potency Microbac technology: 5x more effective delivery Clinically trialled probiotic product Guaranteed potency Clinically trialled probiotic strains 30 VegeCaps 30 VegeCaps AUST ESGATE AUST L 315360 Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven condition-specific probiotic products fueled by novel clinical research programs to cement and extend the evidence base of its probiotic products. Activated Probiotics, Biome's flagship range of novel live-biotherapeutics (probiotics), was created in partnership with world leading organisations in microbiome research and utilises innovative delivery technologies that improves their stability and efficacy. Biome is a certified B Corporation, a designation that a business is meeting high standards of verified performance, accountability and transparency. Company Presentation | August 2023#4Biome Australia Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Certified B Corporation Company Presentation | August 2023 Commercial in confidence#5Biome Australia July 2018 January 2019 March 2019 March 2019 November 2019 June 2019 June 2020 Commercial in confidence November 2020 BIOME AUSTRALIA FOUNDED 6 employees ACTIVATED NUTRIENTS LAUNCH Biome launches its certified. organic range of nutraceuticals SYMBION DISTRIBUTION DEAL Biome gains distribution with pharmaceutical wholesaler Symbion LISTING OF 10 MEDICINES On the Australian Register of Therapeutic Goods ACTIVATED PROBIOTICS LAUNCH Biome launches its condition- specific probiotic range API DISTRIBUTION DEAL Biome gains distribution with pharmaceutical wholesaler API $387K FY19 SALES REVENUE TERRYWHITE CHEMMART DISTRIBUTION DEAL Activated Probiotics launches nationally with TerryWhite Chemmart $833K FY20 SALES REVENUE UK PRACTITIONER MARKET LAUNCH Activated Probiotics launches into the UK Practitioner market January 2021 BIOME OSTEO CLINICAL TRIAL Probone21 clinical trial using Biome Osteo commences in partnership with La Trobe. University and Probi AB February 2021 PRACTITIONER MARKET LAUNCH Activated Probiotics launches into the Australian practitioner market with Oborne Health Supplies and vital.ly February 2021 BIOME DAILY KIDS CLINICAL TRIAL Biome Daily Kids clinical trial commences in partnership with Federation University March 2021 2000 DISTRIBUTION POINTS BIOME LIFT CLINICAL TRIAL In partnership with La Trobe University and Probiotical S.p.A. June 2021 $2.32M FY21 SALES REVENUE July 2021 STRATEGIC DISTRIBUTION PARTNERSHIP Biome signs strategic distribution partnership with TerryWhite Chemmart including exclusive national promotional program September 2021 November 2021 RENER & ARIYA HEALTH DISTRIBUTION DEAL Activated Probiotics increases distribution in the Australian practitioner market with Rener Health Products and Ariya Health B CORPORATION CERTIFICATION <<< BIOME COMPLETES INITIAL PUBLIC OFFERING June 2022 3000 DISTRIBUTION POINTS $4.12M FY22 SALES REVENUE PRICELINE PHARMACY DISTRIBUTION DEAL Biome signs distribution deal with Priceline Pharmacy 30 EMPLOYEES TOTAL OF 14 LISTED MEDICINES ON THE ARTG September 2023 October 2023 PRICELINE PHARMACY ACTIVATED PROBIOTICS PRODUCT LAUNCH INAUGURAL AP SYMPOSIUM 'WOMEN IN THE NEW WORLD <<< March 2023 BIOME LIFT CLINICAL TRIAL PRELIMINARY RESULTS On patients with sub threshold depression May 2023 BIOME RECRUITS HEALTH RETAIL SALES MANAGER FOR THE UK For future pharmacy and health food launch June 2023 BIOME LIFT CLINICAL TRIAL FINAL RESULTS July 2023 <<< $7.23M FY23 SALES July 2023 ACTIVATED PROBIOTICS PRODUCT RANGE EXTENSIONS At Priceline Pharmacy & TerryWhite Chemmart August 2023 LAUNCH 3X NEW PRODUCTS Biome Dental, Lax" and Recovery". Total 17 products. Company Presentation | August 2023 5#6Biome Australia 01. Investment and Business Highlights Company Presentation | August 2023 Commercial in confidence#7Biome Australia Business Highlights Financial performance Commercial in confidence FY23 sales of $7.23m - up 75% (vs pcp) Q1 FY24 revenue target of $2.5m ($10m ARR) Inventory balance of $3m (cost) at June 30 2023 Record monthly sales of $900k in July 2023 Q4 FY23 same stores sales up 27% vs Q3 Gross Margin of 59% Company Presentation | August 2023#8Biome Australia $2,400,000 $2,100,000 $1,800,000 $1,500,000 $1,200,000 $900,000 $600,000 $300,000 Quarterly Sales Growth Target Sep 20 Dec 20 Mar 21 Jun 21 Sep 21 Dec 21 Mar 22 Jun 22 Sep 22 Dec 22 Mar 23 Jun 23 Sep 23 Company Presentation | August 2023 Commercial in confidence#9Biome Australia H1 FY23 Key Stats. - Successes Key Performance Indicators Commercial in confidence Over 4,000 distribution points (Aus) following successful launch with Priceline Pharmacy Three clinical trials on key products, see slide 16 Delivering $50,000sqm gross margin return on floor space in top accounts Average shopper - 2.1 units per transaction and 6 visits per year in pharmacy (TerryWhite) Activated Probiotics #1 growth brand in TerryWhite and Priceline Pharmacy Activated Probiotics #1 growth with Symbion & API - two major pharmacy distributors Company Presentation | August 2023#10Biome Australia 02. Activated Probiotics Range Company Presentation | August 2023 Commercial in confidence 2 10#11Biome Australia O HEROLES A ACTIVATED PROBIOTICS NEW To help support dental health and a healthy oral microbiome ED ACTIVATED PROBIOTICS NEW To help promote bowel regularity and reduce occurrence of bloating TED A ACTIVATED NCS PROBIOTICS NEW To help improve muscle recovery time and reduce mild muscle inflammation Activated Probiotics Biome Dental™ Probiotic Biome Lax™ Probiotic Guaranteed potericy Guaranteed potency Clinically trialled probiotic product Microbac technology: 5x more effective delivery Clinically trialled probiotic product 28 x 1g sachets Mint flavoured powder AUST 1400912 30 VegeCaps Company Presentation | August 2023 Commercial in confidence Biome Recovery™ Probiotic Guaranteed potency Microbac technology: 5x more affictive delivery Canically malted probiotic product Practitioners & Pharmacies CONSUMER BENEFITS 5x more effective delivery - Microbac™ technology Shelf-stable Clinically documented probiotic strains One-a-day formulation HASTA AUST 1400 New product Launches in Q1 50 WigeCaps GMP ONE A DAY FORMULATION FRIDGE FREE VEGAN 11#12Biome Australia Biome Lift™ To support healthy mood balance and enhance sleep quality Biome Baby™ To help support digestive and immune health in infants Biome Daily™ To help enhance immune system function and promote healthy digestion Biome Prenatal+™ To support a healthy pregnancy Biome Osteo™ To help promote bone health in adults Biome Breathe™ To stimulate a healthy immune system response in children Biome IBS™ To relieve the symptoms of medically diagnosed IBS Biome Eczema™ To help reduce the symptoms of mild eczema Biome Lax™ To help promote bowel regularity and reduce occurrence of bloating Biome Daily Kids™ To help reduce the occurrence & duration of common colds Biome Advanced™ To help restore the balance of beneficial gut bacteria after antibiotic use Biome Iron+™ To help increase absorption of dietary iron Biome Her™ To help maintain a healthy vaginal microbiome Biome Dental™ To help support dental health and a healthy oral microbiome Biome Recovery™ To help improve muscle recovery time and reduce mild muscle inflammation Biome Acne™ To help relieve the symptoms of acne Company Presentation | August 2023 Commercial in confidence 12#13Biome Australia 04. Distribution Network and Sales Model Company Presentation | August 2023 Commercial in confidence 13#14Biome Australia Australian Distribution Network Biome Australia currently has over 4000 distribution points, between community pharmacies and independent health practitioners TerryWhite Chemmart-Activated Probiotics #1 growth brand in professional vitamin category Priceline - Activated Probiotics #1 growth brand in professional vitamin category 4000+ Distribution Points Company Presentation | August 2023 Commercial in confidence 14#15Biome Australia Pharmacy Core Ranges Blooms↓ THE CHEMIST priceline pharmacy TerryWhite Chemmart. aadvantage PHARMACY Capital Chemist CHEMISTWORKS A Authorised Distribution Partners api OBORNE C HEALTH SUPPLIES Malouf PHARMACIES Pharmacy+ Choice Pharmacy 777 Ramsay Pharmacy Part of Ramsay Heath Care Pharmacist Advice Slade Pharmacy symbion STP Soul Pattinson Chemist Company Presentation | August 2023 WHOLELIFE PHARMACY & HEALTHFOODS WIZARD Commercial in confidence ARIYA HEALTH RENER HEALTH PRODUCTS Leading the Natural Health Industry in WA vital.ly 15#16Biome Australia A Biome Osteo Probiotic Company Presentation | August 2023 Concerned about bone health Biome Oste Probiot Training and Education Driven Sales Model Commercial in confidence Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • . • • The Biome sales team is a mix of health qualified practitioner education consultants and territory managers Practitioner education consultants undertake high level product detailing and training in community pharmacy and with independent health practitioners High quality training and education develops stronger trust and relationships with health practitioners Biomes support leads to active recommendations of Biome Australia products • • Digital educational content and assets effectively support the national sales team in servicing practitioner markets Health Clinics are provided to key accounts to gain trust and develop existing accounts 16#17Biome Australia 03. Clinical Research Company Presentation | August 2023 Commercial in confidence 花 17#18Biome Australia Clinical pipeline- Indication overview Three ongoing clinical trials and further research opportunities in discussion Commercial in confidence LA TROBE UNIVERSITY BIOME LIFT Assessing the efficacy of the Biome Lift™ Probiotic compared to a placebo in reducing the severity of symptoms in patients with subthreshold depression. Federation University BIOME KIDS Analysing the influence of probiotic use on absenteeism and immune health among children aged 2-5 years attending childcare centres. LA TROBE UNIVERSITY BIOME OSTEO Examining the effect of 12-month supplementation with Biome Osteo on bone metabolism as well as bone mineral density. Endpoints . Measures of anxiety, stress and mood • Effects on biomarkers of inflammatory, immune, and stress responses . The gut microbiota composition and function (via fecal samples assessing microbiota genome and functional predictions of gut microbiota) • Body composition markers . Gastrointestinal symptoms Trial completed & Results Received Publication expected in Q2-3 FY24. Assessment criteria and outcomes: . The duration of symptoms of common infections (gastrointestinal and respiratory infections, etc) The number of children with different varieties of infectious diseases (gastrointestinal infections; respiratory infections; hand foot and mouth disease etc) Use of antibiotics or other medication related to infectious diseases Changes in mood and behaviour (secondary outcome) Recruitment completed, past midway point Trial expected to be completed in Q2 FY24, with preliminary results in Q3 FY24 Endpoints: DXA measurements Blood indices e.g. vitamin D, P1NP (collagen deposition, marker for bone formation) and CTX (marker for bone rate turnover) Gut microbiota composition Body composition . Recruitment Completed and Trial Underway Preliminary results are expected in Q4 FY24 and final results in Q1 FY25 Company Presentation | August 2023 18#19Biome Australia Biome Eczema Probiotic - Patient Results SBO Commercial in confidence "Jude and his mum has said thank you so much. They had tried every skin cream/soap/tablet and nothing has worked up until now. If you recall, Jude told one of the boys at school who asked what was wrong with his skin that he didn't need to worry because soon it would be 'brand new. Looks like he is getting very close to that! I was also told that he could go for a swim in the ocean for the first time the other day without his skin stinging from the salt water." Casey - Pharmacist (QLD) Company Presentation | August 2023 19#20Biome Australia Biome Eczema Probiotic - Patient Results Commercial in confidence Company Presentation | August 2023 20#21Biome Australia 05. International Markets Company Presentation | August 2023 Commercial in confidence 21#22Biome Australia Company Presentation | August 2023 United Kingdom & EU New Growth Markets Commercial in confidence Initial launch phase completed, UK team now generating $500k annualised sales through practitioner market PRACTITIONER (UK/EU) • Add additional distributors in existing markets Add additional European distributors in new markets Increase distribution of activate accounts Improve sell through in active accounts Identify opportunities in mainland Europe Improve marketing and education resources, capabilities and support PHARMACY (UK/IR) - New channel opening in FY24 Gain new ranging Sigma wholesale (UK) and AAH Gain initial distribution in 500 Pharmacies Gain ranging with localised banners HEALTH FOOD UK/IR - New channel opening in FY24 Gain new ranging with CLF Health Food, Hunts and Dundies (UK) and Irish Distributor Gain initial ranging in first 100 HFS in UK and Ireland 22 222#23Biome Australia 06. New Product Development Commercial in confidence 花 ใบ Company Presentation | August 2023 23#24Biome Australia Commercial in confidence KTNNED FOBORES A ACTIVATED PROBIOTICS To help support dental health and a healthy oral microbiome Biome Dental™ Probiotic Guaranteed potency Clinically trialled probiotic product Biome DentalTM Probiotic To help support dental health and a healthy oral microbiome Clinically trialled formulation supported by 10 human trials Guaranteed potency The global periodontal disease treatment market was valued at USD 7.6 billion in 2021 and is expected to reach USD 12.2 billion by the end of 2031, growing at a CAGR of 4.8% from 2022-2031 (1) FORMULATION 28 x 1g sachets Mint flavoured powder AUST L 402932 PRACTITIONER-ONLY PRODUCT Company Presentation | August 2023 ORAL POWDER L. helveticus RosellⓇ-52 (CNCM I-1722) L. rhamnosus Rosell®-11 (CNCM I-1720) B. longum RosellⓇ-175 (CNCM I-3470) Saccharomyces boulardii (CNCM I-1079) Total live bacteria 3.4 BLB 1.8 BLB 0.46 BLB 0.65 BLB 6.3 BLB* *BLB Billion Live Bacteria 24#25Biome Australia 3 2.5 2 1.5 1 0.5 0 Baseline 3 days 14 days 3 2.5 2 * 1.5 1 0.5 0 Baseline 3 days 14 days Company Presentation | August 2023 * Commercial in confidence MEAN PLAQUE SCORE Key Product Research Placebo Chlorhexidine Biome Dental™ Probiotic *p<0.05 vs placebo **p<0.05 vs chlorhexidine MEAN GINGIVAL INDEX Placebo Chlorhexidine Biome Dental™ Probiotic *p<0.05 vs placebo **p<0.05 vs chlorhexidine The probiotic formulation in Biome Dental was compared to placebo and chlorhexidine mouthwash (standard treatment) in 60 healthy children. A significant decrease of plaque score and gingival index was seen on day 3 compared to placebo, and after 14 days of intake, these results persisted (p<0.05). At day 14, plaque score and gingival index were significantly better for Biome Dental compared to chlorhexidine (p<0.05). Sharma, P., Datta, G., Gandhi, K., & Kumar, D. (2019). A comparative evaluation of efficacy of probiotic and chlorhexidine mouthrinses on gingival health and plaque accumulation in 6-9 year old children. International Journal of Applied Dental Sciences, 5(1), 156-162. 25#26Biome Australia Biome Recovery™ Probiotic Commercial in confidence AA ACTIVATED PROBIOTICS ACTIVATED PROBIOTICS To help improve muscle recovery time and reduce mild muscle inflammation Biome Recovery™ Probiotic Guaranteed potency Microbac technology: 5x more effective delivery Clinically trialled probiotic product To help reduce muscle inflammation and recovery time following exercise Clinically-trialled formulation Microbac™ technology: 5x more effective delivery Guaranteed potency The AU sports supplement category was worth AUD 1.4 billion in 2021. APAC is currently the fastest growing region in the global sports nutrition market with an expected 9.8% CAGR to 2028 (1,2) HASTA 30 VegeCaps PRACTITIONER-ONLY PRODUCT Company Presentation | August 2023 VEGECAP FORMULATION Streptococcus thermophilus FP4 (DSM 18616) Bifidobacterium breve BR03 (DSM 16604) Total live bacteria 2.5 BLB 2.5 BLB 5 BLB* *BLB Billion Live Bacteria 26#27Biome Australia CLINICAL TRIAL 50% 40% 30% 20% 10% PRE POST 24HR 48HR 72HR 0% -10% -20% Figure 1. Percent change of interleukin-6 (pro-inflammatory cytokine) compared to baseline before and after exercise. Biome Recovery™ Probiotic Placebo Company Presentation | August 2023 Commercial in confidence Key Product Research A double-blind, randomised, placebo-controlled trial investigated the effect of the probiotic formulation in Biome RecoveryTM Probiotic on physical performance and levels of inflammation following muscle-damaging exercise in healthy men. After 3 weeks of supplementation, the probiotic helped to reduce the negative effect of muscle damage on performance, improved range of motion following muscle-damaging exercises, and lowered levels of the pro-inflammatory cytokine interleukin-6 at baseline and up to 48 hours post-exercise. Jäger, R., Purpura, M., Stone, J. D., Turner, S. M., Anzalone, A. J., Eimerbrink, M. J., Pane, M., Amoruso, A., Rowlands, D. S., & Oliver, J. M. (2016). Probiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 supplementation attenuates performance and range-of-motion decrements following muscle damaging exercise. Nutrients, 8(10), 1-11.#28Biome Australia Commercial in confidence AA ACTIVATED PROBIOTICS ACTIVATED PROBIOTICS Cettle Il To help promote bowel regularity and reduce occurrence of bloating Biome Lax™ Probiotic Guaranteed potency Microbac technology: 5x more effective delivery Clinically trialled probiotic product Biome Lax™ Probiotic To help promote bowel regularity and reduce bloating Clinically-trialled formulation Microbac™ technology: 5x more effective delivery Guaranteed potency The global constipation treatment market size was valued at USD 17.04 billion in 2020 and is projected to reach USD 29.04 Billion by 2028, growing at a CAGR of 6.77% from 2021 to 2028 (1) 30 VegeCaps AUST L407093 PRACTITIONER-ONLY PRODUCT Company Presentation | August 2023 VEGECAP FORMULATION Lactobacillus plantarum LP01 (LMG P-21021) Bifidobacterium breve BR03 (DSM 16604) Total live bacteria 2.5 BLB 2.5 BLB 5 BLB* *BLB Billion Live Bacteria 28#29Biome Australia Key Product Research In a double-blind, randomised, placebo-controlled study across 5 years in over 300 subjects, the product formulation in Biome Lax was found to significantly improve the frequency of bowel movements, consistency of stool, ease of evacuation, sensation of complete emptying, and abdominal bloating compared to placebo (p < 0.001) after 30 days. Drago, L., Cioffi, L., Giuliano, M., Pane, M., Amoruso, A., Schiavetti, I., Reid, G., Ciprandi, G., & PROPAM Study Group. (2022). The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 and Bifidobacterium breve B632 Journal of Immunology Research, 2022, 1-7. 6 5 4 3 2 NUMBER OF WEEKLY EVACUATIONS LEVEL OF DISCOMFORT ASSOCIATED WITH BOWEL MOVEMENTS 3 045 04 0.35 03 0.25 0.2 015 01 0.05 Baseline 15 days 30 days 0 Placebo Probiotic Basaline *p<0.001 compared to placebo Placebo Company Presentation | August 2023 IMPROVEMENT IN BLOATING 2.5 2 1.5 T 0.5 0 Baseline 15 days 30 days Placebo Probiotic 15 days - Probiotic 30 day *p = 0.007 compared to placebo "p<0.001 compared to placebo *p <0.001 compared to placebo Commercial in confidence#30Welcome to the A Marketing ACTIVATED PROBIOTICS® Update#31Biome Australia Commercial in confidence Symposium 2023 The Female Microbiome: Exploring the role of the microbiome throughout the life stages of women Presented by Rebecca Edwards Written by Ben Maketam A ACTIVRE Women in the New World- Hobart Tasmania October 2022. Company Presentation | August 2023 31#32Biome Australia The Microb He Ce ГА A Company Presentation | August 2023 A ACTIVATED ROBIOTICS Next Ger Precision A e he orpti A APP 2023 Commercial in confidence Activated Probiotics largest trade event of the year every March on the Gold Coast. 32#33Biome Australia Educational Topics Commercial in confidence July 2022: Winter Skin | Biome Eczema August 2022: Allergies | Biome Breathe September 2022: Women's Health | Biome Her & Biome Prenatal October 2022: Mental Health | Biome Lift November 2022: Microbac & AP vs. Competitors December 2022: Gut Health | Biome IBS January 2023: Back to School | Biome Daily Kids & Biome Baby February 2023: Preventative Women's Health | Biome Osteo & Biome Iron & Biome Her March/April 2023: Strain Specificity Public Health Campaign May 2023: Gut-Skin Axis Biome Eczema & Biome Acne June 2023: Adult Immune Health | Biome Daily & Biome Advanced Company Presentation | August 2023 33#34Commercial in confidence Public Health Campaign It's what's on the inside that counts 34#35Commercial in confidence March and April were dedicated to our first Public Health Campaign, a national rollout designed to educate the public about the importance of strain specificity in probiotic supplements. The multimedia campaign spanned above-the-line and below-the-line advertising, including on-demand TV, OOH, all owned digital channels (blog, website, socials, eDMs), in-store signage and consumer resources. Based on post-campaign reports, our messaging reached close to 1.5 million people. 35#36Biome Australia Trade Marketing 1. Window Adhesives 2. Know Your Strain Booklet 3. TV Loops Company Presentation | August 2023 Scriptic A ACTIVATED PROBIOTICS ACTIVATED PROBIOTICS .COM.AU Have you heard about the gut-skin axis? Ask your pharmacist about our probiotics for skin health Full probiotic range available in store now! Stacadast AA ACTIVATED ACTIVATED BCS PROBIOTICS To help relieve the symptoms of acne Biome Acne™ Probiotic AA A ACTIVATED PROBIOTICS ACTIVATED PROBIOTICS To help reduce the symptoms of mid eczema Biome Eczema" Probiotic Guaranteed potenc Microbatechnology Exmore effective divery Clinically trated probate prodier Glipranted octice Microbia techology medialy Cervically trated pritione si 30 VegeCal 30x Lay sachin fan give Always read the fabel. Use only as directed 36#37Biome Australia Summary FY23 sales of $7.23m - up 75% (vs pcp) Q1 FY24 revenue target of $2.5m ($10m ARR) Inventory balance of $3m (cost) at June 30 2023 Record monthly sales of $900k in July 2023 Q4 FY23 same stores sales up 27% vs Q3 Gross Margin of 59% Over 4,000 distribution points (Aus) • • . Three clinical trials on key products, see slide 16 Average shopper - 2.1 units per transaction and 6 visits per year in pharmacy (TerryWhite) Activated Probiotics #1 growth brand in TerryWhite and Priceline Pharmacy Activated Probiotics #1 growth with Symbion & API Delivering ~$50,000sqm gross margin return on floor space in top accounts Company Presentation | August 2023 Commercial in confidence 37#38Biome Australia BIOME AUSTRALIA Contact details: Blair Norfolk, CEO Commercial in confidence Douglas Loh, CFO e: [email protected] Websites: biomeaustralia.com activated probiotics.com.au Certified B Corporation This company meets high standards of social and environmental impact. Company Presentation | August 2023